Director, Portfolio Strategy Inflammation & Immunology
About the role
The Director, Portfolio Strategy within the Inflammation & Immunology (I&I) Early Commercial Business, part of the Global Commercial Strategy organization, supports the I&I Portfolio Strategy & Disease Area Lead ("DAL"). This role is pivotal in shaping portfolio strategy, early commercial assessments, and investment decision support across the I&I pipeline.
Responsibilities
Support development of long-range commercial and portfolio strategy for the I&I Early Commercial Business, spanning early pipeline assets, lifecycle opportunities, and emerging disease areas.
Synthesize scientific, clinical, commercial, access, and competitive insights to inform portfolio priorities and strategic trade-offs.
Assess opportunities across near-, mid-, and long-term horizons to identify areas of differentiated value creation for Pfizer's I&I portfolio.
Translate portfolio strategy into clear recommendations, implications, and decision materials for leadership and governance discussions.
Monitor shifts in the I&I scientific and competitive landscape to identify emerging trends, risks, and potential development opportunities.
Develop and refine early commercial assessments for I&I pipeline assets, indications, mechanisms, and disease-area opportunities.
Support development of product concepts, target product profile input, positioning hypotheses, market archetypes, and commercial opportunity assessments.
Translate unmet need, standard of care, competitive dynamics, patient/HCP insights, and access considerations into differentiated commercial hypotheses.
Provide commercial input to clinical development, evidence generation, lifecycle, and indication sequencing discussions in partnership with cross-functional colleagues.
Help identify key value drivers, risks, uncertainties, and evidence needs that may influence future launch potential and portfolio value.
Partner with the I&I Portfolio Strategy & DAL and cross-functional stakeholders to ensure a strong commercial voice is incorporated into early development and portfolio decisions.
Support preparation for governance forums, portfolio reviews, strategy discussions, and investment decision meetings.
Build trusted working relationships across R&D, Medical Affairs, GASP, BAI, Competitive Intelligence, Business Development, and Commercial Regions.
Influence without direct authority by aligning stakeholders around shared insights, strategic choices, and implications for the I&I portfolio.
Use AI-enabled tools to support scientific and competitive landscape synthesis, market insight generation, scenario development, and strategy workstream efficiency.
Apply AI-augmented approaches to accelerate analysis, identify patterns across complex data sources, and improve quality and consistency of strategic outputs.
Help embed responsible, compliant AI-enabled ways of working into early commercial strategy, portfolio assessment, and decision-support processes.
Stay current on emerging tools and practices that can strengthen commercial strategy development and portfolio decision-making.
Requirements
Applicant must have a bachelor's degree with at least 8 years of experience; OR a master's degree with at least 7 years of experience; OR a PhD with 5+ years of experience.
Experience in pharmaceutical, biotechnology, life sciences, strategy consulting, corporate strategy, commercial development, business development, forecasting, market research, analytics, or related field.
Strong strategic and analytical skills, with ability to synthesize complex scientific, clinical, market, access, and competitive information into clear recommendations.
Experience supporting portfolio strategy, early commercial assessment, business case development, opportunity assessment, or cross-functional strategic planning.
Demonstrated ability to manage multiple priorities and deliver high-quality work in a matrixed environment.
Strong communication, organization, problem-solving, and stakeholder management skills.